These injections, initially approved for controlling type 2 diabetes , have seen increased use due to their impact on weight loss . Semaglutide (brand name copyright) is a brand name of the active ingredient, https://elijahvikg936037.dsiblogger.com/74203231/copyright-the-glp-1-receptor-agonists-what-you-need-to-know